Michael Lane - 14 Feb 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
Issuer symbol
IDXX
Transactions as of
14 Feb 2023
Net transactions value
-$138,504
Form type
4
Filing time
16 Feb 2023, 17:51:50 UTC
Previous filing
10 Feb 2023
Next filing
08 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +196 +4.5% $0.000000 4,563 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +181 +4% $0.000000 4,744 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +173 +3.6% $0.000000 4,917 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +161 +3.3% $0.000000 5,078 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +204 +4% $0.000000 5,282 14 Feb 2023 Direct
transaction IDXX Common Stock Tax liability $138,504 -275 -5.2% $503.65 5,007 14 Feb 2023 Direct
holding IDXX Common Stock 592 14 Feb 2023 by spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -196 -6.4% 2,886 14 Feb 2023 Common Stock 196 Direct F2, F7
transaction IDXX Restricted Stock Unit Options Exercise -181 -6.3% 2,705 14 Feb 2023 Common Stock 181 Direct F3, F7
transaction IDXX Restricted Stock Unit Options Exercise -173 -6.4% 2,532 14 Feb 2023 Common Stock 173 Direct F4, F7
transaction IDXX Restricted Stock Unit Options Exercise -161 -6.4% 2,371 14 Feb 2023 Common Stock 161 Direct F5, F7
transaction IDXX Restricted Stock Unit Options Exercise -204 -8.6% 2,167 14 Feb 2023 Common Stock 204 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.
F3 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F7 Not applicable.